The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity
Open Access
- 1 October 2003
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (10), 1919-1926
- https://doi.org/10.1194/jlr.m300129-jlr200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Oxidized LDL and HDL: antagonists in atherothrombosisThe FASEB Journal, 2001
- Hydrolysis of platelet-activating factor by human serum paraoxonaseBiochemical Journal, 2001
- The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart diseaseAtherosclerosis, 2000
- Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid AtherosclerosisStroke, 1998
- Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase ActivitiesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- A Mutation in Plasma Platelet-Activating Factor Acetylhydrolase (Val 279 →Phe) is a Genetic Risk Factor for StrokeStroke, 1997
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Loss of Activity of Plasma Platelet-Activating Factor Acetylhydrolase Due to a Novel Gln281→Arg MutationBiochemical and Biophysical Research Communications, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993